Format

Send to

Choose Destination
Arthritis Rheum. 1997 Dec;40(12):2207-11.

A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans.

Author information

1
The Children's Hospital of Philadelphia, University of Pennsylvania, 19104, USA.

Abstract

OBJECTIVE:

The polymorphic tumor necrosis factor alpha (TNFalpha) gene encodes a cytokine involved in inflammation, angiogenesis, and apoptosis. One polymorphic variant is associated with increased production of TNFalpha. This study examined the frequency of this polymorphic variant in African-American patients with systemic lupus erythematosus (SLE) compared with controls.

METHODS:

We determined the gene frequency of the polymorphic variant of TNFalpha in an African-American SLE patient population and in a geographically matched African-American control population.

RESULTS:

The gene frequency of the TNFalpha -308A polymorphism was higher in the African-American SLE population than in the control population. This relationship was independent of major histocompatibility complex DR alleles.

CONCLUSION:

The TNFalpha -308A polymorphism is associated with an increased risk of SLE in African-Americans.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center